Drug Development in Dementia

Dementia is a progressive, irreversible decline in cognition that, by definition, impacts on a patient pre-existing level of functioning. The clinical syndrome of dementia has several aetiologias of which Alzheimer’s disease (AD) is the most common. Drug development in AD is based on evolving pathophysiological theory. Disease modifying approaches include the targeting of amyloid processing, aggregation of tau, insulin signaling, neuroinflammation and neurotransmitter dysfunction, with efforts thus far yielding abandoned hopes and ongoing promise. Reflecting its dominance on the pathophysiological stage the amyloid cascade is central to many of the emerging drug therapies.

 

  • New drugs in Dementia
  • Drug discovery
  • Predementia AD

Related Conference of Drug Development in Dementia

October 23-24, 2020

International Conference on Neurology and Psychiatry

Paris, France
October 26-27, 2020

2nd World Summit on Neurology, Psychiatric Disorders and Mental health

Singapore City, Singapore
October 28-29, 2020

11th Annual Congress on Bioenergy and Biofuels

Dubai, UAE
October 28-29, 2020

International Conference on Stress Management

Dubai, UAE
October 30-31, 2020

World Physicians Congress

Dubai, UAE
November 02-03, 2020

33rd World Neuroscience and Neurology Conferences

Rome, Italy
November 09-10, 2020

32nd World Congress on Neurology and Neuroscience

Budapest, Hungary
November 09-10, 2020

12th World Congress on Alzheimers Disease & Dementia

Budapest, Hungary
November 16-17, 2020

9th International Conference on Smart Materials and Structures

Amsterdam, Netherlands
November 19-20, 2020

8th World Congress on Depression and Anxiety

Tokyo, Japan
November 19-20, 2020

6th World Congress on Spine and Spinal Disorders

Tokyo, Japan
November 19-20, 2020

2ndInternational Conference on Pharmacology and Toxicology

Bali, Indonesia
November 23-24, 2020

15th World Conference on Pharmaceutical Chemistry

London, UK
November 23-24, 2020

4th International Conference on Addiction Therapy

Bali, Indonesia
November 23-24, 2020

Quantum Technology Summit

Paris, France
November 27-27, 2020

International Conference on Neurologists

Dubai, UAE
November 30-December 1, 2020

3rd International Conference on Palliativecare Health

Barcelona, Spain
December 03-04, 2020

2nd World Congress on Neurology

Osaka, Japan
December 07-08, 2020

World Neurology Congress

Dubai, UAE
December 07-08, 2020

International conference on Dementia & Dementia Care

Tokyo, Japan
December 07-08, 2020

3rd World Neuron Congress

Dubai, UAE
December 07-08, 2020

9th World Congress on Neuro Infection and Neuro Immunology

Prague, Czech Republic
December 10-10, 2020

3rd Annual Conference on Hematologists

Dubai, UAE
February 10-11, 2021

2nd Global Summit on Neurology and Neurosurgery

Amsterdam, Netherlands
February 22-23, 2021

30th World Congress on Neurology and Therapeutics

Barcelona, Spain
February 25-26, 2021

3rd World Congress on Epilepsy and Brain Disorders

Dubai, UAE
April 05-06, 2021

16th Annual Conference on Dementia and Alzheimers Disease

Kualalumpur, Malaysia
April 23-24, 2021

Annual Congress on Mental Health & Neurology

Berlin, Germany
June 14-15, 2021

35th European Neurology Congress

London, UK
June 28-29, 2021

13th International Conference on Vascular Dementia

Prague, Czech Republic
July 26-27, 2021

8th International Conference on ENT Surgery

London, Aland Islands
September 06-07, 2021

7th World Congress on Parkinsons & Huntington Disease

Rome, Italy
September 16-17, 2021

International Conference on Neurosurgery & Neurology

Paris, France

Drug Development in Dementia Conference Speakers

Recommended Sessions

Related Journals

Are you interested in